<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2013042313100N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2013-07-06</date_registration>
      <primary_sponsor>Kerman medical university-dean of research</primary_sponsor>
      <public_title>study of transcranial magnetic stimulation effect on motor imagery rehabilitation and movement improvment in multiple sclerosis patients</public_title>
      <acronym></acronym>
      <scientific_title>study of transcranial magnetic stimulation effect on motor imagery rehabilitation and movement improvment in multiple sclerosis patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/13034</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>multiple sclerosis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention: transcranial magnetic stimulation. Duration: 10 sessions( 5  sessions in one week and other 5 sessions in next week). Intervention 2: Control: no treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nasser Zangiabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ebn Sina St.</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7619813159</zip>
        <telephone>+98 34 1226 4271</telephone>
        <email>nzangiabadi1@gmail.com</email>
        <affiliation>Kerman Neuroscience Research Center</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nasser Zangiabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ebn Sina St.</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7619813159</zip>
        <telephone>+98 34 1226 4271</telephone>
        <email>nzangiabadi1@gmail.com</email>
        <affiliation>Kerman Neuroscience Research Center</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients (20 to 40 years old ) met the Mc Donald criteria for diagnosis of MS.All of them belong to relapsing remitting MS subgroup.&#13;
The study exclusion criteria included patients with EDSS &gt; 3.5; new clinical attack during 3 months prior to the study; other neurological diseases (stroke, seizure, etc.); head trauma, chronic psychiatric disorder. Patients were right-handed based on the Edinburgh Handedness Inventory. Fatigue score based on Fatigue Severity Scale  questionnaire should be less than 37. Depression score based on Beck Depression questionnaire should be less  than 21. Mini mental state examination score should be  more than 24.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G35</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention: transcranial magnetic stimulation. Duration: 10 sessions( 5  sessions in one week and other 5 sessions in next week).</i_keyword>
      <i_keyword>Control: no treatment</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mental rotation ability. Timepoint: befor rTMS implementation and after  the 10th rTMS session. Method of measurement: Reaction time and accuracy (percent of correct response) were recorded.</prim_outcome>
      <prim_outcome>Upper limb imagery chronometry. Timepoint: before rTMS implementation and after  the 10th rTMS session. Method of measurement: (real performance-motor imagery)/real performance.</prim_outcome>
      <prim_outcome>Upper limb function. Timepoint: before rTMS implementation and after  the 10th rTMS session. Method of measurement: number of moved blocks in 1 minute.</prim_outcome>
      <prim_outcome>Upper limb function. Timepoint: before rTMS implementation and after  the 10th rTMS session. Method of measurement: recorded time for moving nine pegs.</prim_outcome>
      <prim_outcome>Lower limbs function. Timepoint: before rTMS implementation and after  the 10th rTMS session. Method of measurement: recorded time for walking 25 foots.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>PASAT score. Timepoint: before rTMS implementation and after  the 10th rTMS session. Method of measurement: total number of accurate sum.</sec_outcome>
      <sec_outcome>Motor and visual  imagery vividness. Timepoint: before rTMS implementation. Method of measurement: kinesthetic and visual imagery questionnaire.</sec_outcome>
      <sec_outcome>Global cognitive function. Timepoint: before rTMS implementation. Method of measurement: mini mental state examination.</sec_outcome>
      <sec_outcome>Depression score. Timepoint: before rTMS implementation. Method of measurement: beck depression questionnaire.</sec_outcome>
      <sec_outcome>Fatigue score. Timepoint: before rTMS implementation. Method of measurement: fatigue Severity scale questionnaire.</sec_outcome>
      <sec_outcome>SDMT score. Timepoint: before rTMS implementation and after the 10th rTMS session. Method of measurement: number of correct digits in 90 second.</sec_outcome>
      <sec_outcome>Brief visuospatial memory test-revised score. Timepoint: before rTMS implementation and after the 10th rTMS session. Method of measurement: number of correct responses after 25 minutes.</sec_outcome>
      <sec_outcome>Judgment of line orientation score. Timepoint: before rTMS implementation and after the 10th rTMS session. Method of measurement: number of correct angles.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kerman medical university-dean of research</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-11-10</approval_date>
        <contact_name>Ethics Committee of Kerman University of Medical Science</contact_name>
        <contact_address>Ebn Sina St. Kerman  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
